Companies / PTC Therapeutics Inc

PTC Therapeutics Inc

Nasdaq: PTCTCIK 1070081WARREN, NJptcbio.com

Financials · FY2025

Revenue$1.73B
Net income$682.64M
Total debt$535.52M
Cash$1.05B
Diluted EPS$7.78
Shares outstanding83.5M

Ownership

83.5M shares outstanding · as of Jul 29, 2026
1.4%Insiders
Ownership
Insiders1.43%1,191,633
10%+ / strategic20.97%17,500,118
Institutions107.02%89,321,745
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 17

View all →
Insider% of sharesShares
Klein Matthew B.CEOCHIEF EXECUTIVE OFFICER · Director
0.47%393,998
0.20%163,266
Boulding Mark ElliottEXEC. VP AND CLO
0.13%105,272
Gravier PierreCHIEF FINANCIAL OFFICER
0.10%87,318
Golden Lee ScottEVP & CHIEF MEDICAL OFFICER
0.09%79,115
Pauwels EricCHIEF BUSINESS OFFICER
0.09%73,411
Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER
0.08%70,199
Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
0.08%62,874
0.03%22,500
0.03%22,500

Institutional holders 359

View all →
HolderValue% of shares
BlackRock, Inc.$1.14B16.73%
Vanguard Group Inc$668.69M10.55%
RTW Investments, LP$588.42M9.28%
Janus Henderson Group PLC$490.00M8.62%
State Street Corporation$375.14M5.51%
Toronto Dominion Bank$314.34M4.96%
Wellington Management Group LLP$293.77M4.63%
Armistice Capital, LLC$212.83M3.36%
Geode Capital Management, LLC$150.59M2.65%
Fmr LLC$127.71M2.01%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 1, 2026Almstead Neil Gregory
Executive
SellCommon Stock$2.71M-39K
-35.13%
72,747
0.09% of shares
medium
Jun 17, 2026Utter Christine Marie
Executive
SellCommon Stock$1.49M-20K
-21.90%
70,199
0.08% of shares
medium
Jun 10, 2026Pauwels Eric
Executive
SellCommon Stock$1.32M-18K
-19.31%
73,411
0.09% of shares
medium
Jun 25, 2026Almstead Neil Gregory
Executive
SellCommon Stock$980.8K-11K
-15.86%
60,137
0.07% of shares
medium
Mar 10, 2026Okey Stephanie
Director
SellCommon Stock$980.0K-14K
-63.64%
8,000
<0.01% of shares
medium
Jun 22, 2026Almstead Neil Gregory
Executive
SellCommon Stock$977.8K-12K
-14.46%
71,756
0.09% of shares
medium
Jun 22, 2026Almstead Neil Gregory
Executive
SellCommon Stock$943.6K-12K
-16.19%
60,137
0.07% of shares
medium
Jan 2, 2026Steele Glenn Jr Md Phd
Director
SellCommon Stock$916.2K-12K
-39.34%
18,500
0.02% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Wellington Management Group LLPPassive13G/A
State Street CorporationPassive13G4,206,126
Toronto Dominion BankPassive13G4,138,215
Janus Henderson Group PLCPassive13G
Toronto Dominion BankPassive13G/A3,025,945
Janus Henderson Group PLCPassive13G/A
Vanguard Portfolio ManagementPassive13G4,871,329

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PTCT69366J200